XML 69 R38.htm IDEA: XBRL DOCUMENT v2.4.0.8
INTANGIBLE ASSETS AND GOODWILL (Details) (USD $)
4 Months Ended 12 Months Ended 88 Months Ended 12 Months Ended 4 Months Ended 4 Months Ended 4 Months Ended 12 Months Ended 88 Months Ended
Dec. 31, 2012
Aug. 31, 2012
Aug. 31, 2011
Aug. 31, 2010
Dec. 31, 2012
Dec. 14, 2007
Encode Pharmaceuticals Inc [Member]
Aug. 31, 2012
2009 Merger [Member]
Dec. 31, 2012
2009 Merger [Member]
Aug. 31, 2011
2009 Merger [Member]
Dec. 31, 2012
IP license for RP103 [Member]
Dec. 31, 2012
IP license for RP103 [Member]
Encode Pharmaceuticals Inc [Member]
Aug. 31, 2012
IP license for RP103 [Member]
Encode Pharmaceuticals Inc [Member]
Aug. 31, 2011
IP license for RP103 [Member]
Encode Pharmaceuticals Inc [Member]
Dec. 31, 2012
Out license [Member]
Dec. 31, 2012
Out license [Member]
2009 Merger [Member]
Aug. 31, 2012
Out license [Member]
2009 Merger [Member]
Aug. 31, 2011
Out license [Member]
2009 Merger [Member]
Dec. 31, 2012
Research and Development Expense [Member]
Aug. 31, 2012
Research and Development Expense [Member]
Aug. 31, 2011
Research and Development Expense [Member]
Aug. 31, 2010
Research and Development Expense [Member]
Dec. 31, 2012
Research and Development Expense [Member]
Acquired Finite-Lived Intangible Assets [Line Items]                                            
Impairment of assets charge to research and development expense             $ 900,000                              
Summary of intangible assets [Abstract]                                            
Total intangible assets 2,860,000 2,860,000 3,760,000   2,860,000   0 0 900,000   2,620,000 2,620,000 2,620,000   240,000 240,000 240,000          
Less accumulated amortization (704,000) (655,000) (509,000)   (704,000)                                  
Intangible assets, net 2,156,000 2,205,000 3,251,000   2,156,000 2,600,000 200,000                              
Estimated useful life 20 years                 20 years 20 years     16 years 16 years              
Amortization of intangible assets to research and development expense 49,000 146,000 153,000 152,000 746,000                         49,000 146,000 153,000 152,000 746,000
Actual and estimated amortization expense for intangible assets [Abstract]                                            
2013 146,000       146,000                                  
2014 146,000       146,000                                  
2015 146,000       146,000                                  
2016 146,000       146,000                                  
2017 $ 146,000       $ 146,000